Benzinga | May 6, 2021 04:53PM EDT

Guardant Health Q1 EPS $(0.49) Beats $(0.89) Estimate, Sales $78.67M Beat $73.75M Estimate

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.89) by 44.94 percent. This is a 68.97 percent decrease over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $78.67 million which beat the analyst consensus estimate of $73.75 million by 6.66 percent. This is a 16.52 percent increase over sales of $67.51 million the same period last year.